Expression and clinical significance of the Trop‑2 gene in advanced non‑small cell lung carcinoma

Jiang,Aigui; Gao,Xiaoyan; Zhang,Degeng; Zhang,Lixin; Lu,Huiyu

doi:10.3892/ol.2013.1368

August 2013 Volume 6 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

August 2013 Volume 6 Issue 2

Full Size Image

Article

Expression and clinical significance of the Trop‑2 gene in advanced non‑small cell lung carcinoma

Authors:
- Aigui Jiang
- Xiaoyan Gao
- Degeng Zhang
- Lixin Zhang
- Huiyu Lu
View Affiliations / Copyright

Affiliations: Department of Respiratory Medicine, Taizhou People's Hospital Affiliated to Medical College of The Nantong University, Taizhou, Jiangsu 225300, P.R. China, Department of Oncology, Taizhou People's Hospital Affiliated to Medical College of The Nantong University, Taizhou, Jiangsu 225300, P.R. China, Institute of Clinical Medicine, Taizhou People's Hospital Affiliated to Medical College of The Nantong University, Taizhou, Jiangsu 225300, P.R. China
Pages: 375-380
|
Published online on: May 29, 2013

https://doi.org/10.3892/ol.2013.1368
Expand metrics +

Abstract

The Trop‑2 gene has been examined in various carcinomas and is reported to be significantly associated with prognosis. Little is known with regard to Trop‑2 gene expression in advanced non‑small cell lung carcinoma (NSCLC). The present study investigated the expression of Trop‑2 and its association with the prognosis of advanced NSCLC. The clinical records of 87 patients with advanced NSCLC, consisting of 37 cases of squamous cell carcinoma (SCC) and 50 cases of adenocarcinoma (AdC), together with 17 tumor‑adjacent normal tissues, were retrospectively evaluated. Trop‑2 expression was measured using an immunohistochemical method and its association with clinicopathological data and prognosis was also evaluated. The expression of Trop‑2 was significantly higher in the cancer tissues compared with the tumor‑adjacent normal tissues, and significantly higher in SCC compared with AdC (P=0.018). In SCC, the overexpression of Trop‑2 was only correlated with the histological grade of the tumor (P=0.035) and no correlation was observed with gender, age, lymph node metastasis, TNM stage or Eastern Cooperative Oncology Group (ECOG) performance status (PS). In AdC, the overexpression of Trop‑2 was correlated with the histological grade, lymph node metastasis and TNM stage (P=0.01, 0.024 and 0.015, respectively), while no correlation with gender, age or ECOG‑PS was observed. The survival frequency was significantly higher in the Trop‑2‑negative patients compared with the Trop‑2‑positive patients [17.25 months (95% CI, 14.922‑19.577) vs. 13.274 months (95% CI, 11.507‑15.041); P=0.008]. The survival time was significantly longer in the Trop‑2‑negative AdC patients [17.275 months (95% CI, 14.575‑19.975) vs. 11.469 months (95% CI, 11.507‑15.041); P=0.002], but not in the SCC patients [17.167 months (95% CI, 12.428‑21.906) vs. 14.647 months (95% CI, 12.062‑17.232); P=0.276]. The multivariate analysis revealed that Trop‑2 expression [hazard ratio (HR) 2.381; P=0.038], TNM stage (HR, 2.193; P=0.03) and ECOG‑PS (HR, 2.696; P=0.007) were independent predictors for the survival outcome of patients with AdC. These results suggest that Trop‑2 overexpression is closely correlated with an unfavorable prognosis in advanced NSCLC. Trop‑2 is an independent prognostic marker and a potential new therapeutic target in advanced AdC.

View Figures

View References

1.	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2.	Jiang HF and Bo JJ: Trophoblastic cell surface protein 2 and tumor. J Int Oncol. 39:96–98. 2012.(In Chinese).
3.	Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K and Mori M: Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res. 12:3057–3063. 2006. View Article : Google Scholar : PubMed/NCBI
4.	Fong D, Spizzo G, Gostner JM, et al: TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol. 21:186–191. 2008.PubMed/NCBI
5.	Fong D, Moser P, Krammel C, et al: High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer. 99:1290–1295. 2008. View Article : Google Scholar : PubMed/NCBI
6.	Wang J, Day R, Dong Y, Weintraub SJ and Michel L: Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol Cancer Ther. 7:280–285. 2008. View Article : Google Scholar : PubMed/NCBI
7.	Kobayashi H, Minami Y, Anami Y, et al IASLC International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions: Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma. Virchows Arch. 457:69–76. 2010. View Article : Google Scholar : PubMed/NCBI
8.	Pak MG, Shin DH, Lee CH and Lee MK: Significance of EpCAM and TROP2 expression in non-small cell lung cancer. World J Surg Oncol. 10:532012. View Article : Google Scholar : PubMed/NCBI
9.	Groome PA, Bolejack V, Crowley JJ, et al IASLC International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions: The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2:694–705. 2007. View Article : Google Scholar
10.	Calabrese G, Crescenzi C, Morizio E, Palka G, Guerra E and Alberti S: Assignment of TACSTD1 (alias TROP1, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias TROP2, M1S1) to human chromosome 1p32 by in situ hybridization. Cytogenet Cell Genet. 92:164–165. 2001. View Article : Google Scholar : PubMed/NCBI
11.	Taylor JT, Zeng XB, Pottle JE, et al: Calcium signaling and T-type calcium channels in cancer cell cycling. World J Gastroenterol. 14:4984–4991. 2008. View Article : Google Scholar : PubMed/NCBI
12.	Nelsen CJ, Kuriyama R, Hirsch B, et al: Short term cyclin D1 overexpression induces centrosome amplification, mitotic spindle abnormalities, and aneuploidy. J Biol Chem. 280:768–776. 2005. View Article : Google Scholar : PubMed/NCBI
13.	Cubas R, Zhang S, Li M, Chen C and Yao Q: Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer. 9:2532010. View Article : Google Scholar : PubMed/NCBI
14.	Zhang B, Yao YF and Zhou P: Two novel mutations identified in two Chinese gelatinous drop-like corneal dystrophy families. Mol Vis. 13:988–992. 2007.PubMed/NCBI
15.	Markoff A, Bogdanova N, Uhlig CE, Groppe M, Horst J and Kennerknecht I: A novel TACSTD2 gene mutation in a Turkish family with a gelatinous drop-like corneal dystrophy. Mol Vis. 12:1473–1476. 2006.PubMed/NCBI
16.	Alavi A, Elahi E, Tehrani MH, et al: Four mutations (three novel, one founder) in TACSTD2 among Iranian GDLD patients. Invest Ophthalmol Vis Sci. 48:4490–4497. 2007. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Expression and clinical significance of the Trop‑2 gene in advanced non‑small cell lung carcinoma

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Related Articles